Glucagon Delivery System Treats Post-Bariatric Hypoglycemia
By HospiMedica International staff writers Posted on 30 Jan 2020 |

Illustration
A new study describes a closed-loop system that automatically provides patients with an appropriate, as-needed dose of liquid glucagon to treat post-bariatric hypoglycemia (PBH).
Developed by researchers at the Joslin Diabetes Center (Boston, MA, USA) and Harvard University (Cambridge, MA, USA), the system is comprised of a continuous glucose monitor (CGM) device and a patch infusion glucagon pump. A glucose-responsive automated delivery system detects hypoglycemia, which is then mitigated via an algorithmic application that delivers up to two doses of glucagon when triggered. The closed-loop system allows patients to go about their daily activities without the fear of dipping into dangerous hypoglycemia.
In a study of the system that involved 12 patients (mean age 52 years), hypoglycemia was induced in each patient after being hooked up to the system, and the algorithm was allowed to sense impending low blood sugar levels and automatically deliver an appropriate glucagon dose, under supervision by the medical team. The results showed that nadir plasma glucose was higher with glucagon that with placebo and that no rebound hyperglycemia occurred. The study was published on November 12, 2019, in The Journal of Clinical Endocrinology & Metabolism.
“Post-bariatric hypoglycemia is a profoundly life-altering condition for patients. Having unpredictable hypoglycemia that people can't detect is really an unsafe situation. This system provides a way to help individuals keep their glucose in a safe range,” said senior author Mary Elizabeth Patti, MD, of Harvard Medical School and Joslin. “Using the system to detect an upcoming severe low and treat it before it gets unsafe would be so important to improve safety and quality of life of patients with this type of hypoglycemia.”
“The way that we look at it, it is very similar to how in your car, you have an airbag. You don't use that airbag every time that you stop at a traffic light, but when there is a severe event and there's a need to prevent catastrophe, the airbag will be deployed,” said study co-author Eyal Dassau, PhD, director of the Biomedical Systems Engineering Research Group at Harvard. “We employing the same idea for the glucagon system: we detect, we analyze and then we deliver automatically a mini dose of glucagon. You can start with a very low dose of glucagon as it's needed, and add an additional small dose if indicated without overdosing.”
PBH can occur in the context of the dumping syndrome, which can occur postoperatively in up to half of gastric bypass patients with ingestion of simple sugars. Early dumping, a result of rapid emptying of food into the jejunum due to surgically altered anatomy, is characterized by flushing, tachycardia, abdominal pain, and diarrhea. Late dumping occurs after meal ingestion and is a consequence of the brisk insulin response to the hyperglycemia that results from the rapid absorption of simple sugars from the proximal small intestine.
Related Links:
Joslin Diabetes Center
Harvard University
Developed by researchers at the Joslin Diabetes Center (Boston, MA, USA) and Harvard University (Cambridge, MA, USA), the system is comprised of a continuous glucose monitor (CGM) device and a patch infusion glucagon pump. A glucose-responsive automated delivery system detects hypoglycemia, which is then mitigated via an algorithmic application that delivers up to two doses of glucagon when triggered. The closed-loop system allows patients to go about their daily activities without the fear of dipping into dangerous hypoglycemia.
In a study of the system that involved 12 patients (mean age 52 years), hypoglycemia was induced in each patient after being hooked up to the system, and the algorithm was allowed to sense impending low blood sugar levels and automatically deliver an appropriate glucagon dose, under supervision by the medical team. The results showed that nadir plasma glucose was higher with glucagon that with placebo and that no rebound hyperglycemia occurred. The study was published on November 12, 2019, in The Journal of Clinical Endocrinology & Metabolism.
“Post-bariatric hypoglycemia is a profoundly life-altering condition for patients. Having unpredictable hypoglycemia that people can't detect is really an unsafe situation. This system provides a way to help individuals keep their glucose in a safe range,” said senior author Mary Elizabeth Patti, MD, of Harvard Medical School and Joslin. “Using the system to detect an upcoming severe low and treat it before it gets unsafe would be so important to improve safety and quality of life of patients with this type of hypoglycemia.”
“The way that we look at it, it is very similar to how in your car, you have an airbag. You don't use that airbag every time that you stop at a traffic light, but when there is a severe event and there's a need to prevent catastrophe, the airbag will be deployed,” said study co-author Eyal Dassau, PhD, director of the Biomedical Systems Engineering Research Group at Harvard. “We employing the same idea for the glucagon system: we detect, we analyze and then we deliver automatically a mini dose of glucagon. You can start with a very low dose of glucagon as it's needed, and add an additional small dose if indicated without overdosing.”
PBH can occur in the context of the dumping syndrome, which can occur postoperatively in up to half of gastric bypass patients with ingestion of simple sugars. Early dumping, a result of rapid emptying of food into the jejunum due to surgically altered anatomy, is characterized by flushing, tachycardia, abdominal pain, and diarrhea. Late dumping occurs after meal ingestion and is a consequence of the brisk insulin response to the hyperglycemia that results from the rapid absorption of simple sugars from the proximal small intestine.
Related Links:
Joslin Diabetes Center
Harvard University
Latest Surgical Techniques News
- Neuroform Atlas Stent-Assisted Coiling Found Effective Even in Smaller Arteries
- New Surgical Technique Safely Removes Giant Nerve Tumors
- Breakthrough Polymer Significantly Improves Safety of Implantable Medical Devices
- First-Ever Technology Makes Blood Translucent During Surgery
- Tibia Nailing System with Novel Side-Specific Nails to Revolutionize Fracture Surgery
- New Imaging Probe to Transform Brain Cancer Surgery
- New Technology More Than Doubles Success Rate for Blood Clot Removal
- Surgical Ablation During CABG Improves Survival in Patients with Preexisting Atrial Fibrillation
- New Battery Technology Delivers Additional Power to Implantable Medical Devices
- New Model Reveals Optimal Positioning of Orthopedic Screws in Fractures
- Non-Invasive Tool for Removing Lung Cancer Tumors Reduces Surgical Trauma
- Advanced Imaging Endoscopes to Revolutionize Detection and Treatment of Gastrointestinal Disorders
- Novel Mechanical Heart Valve Improves Blood Flow and Lowers Risk of Blood Clots
- First-of-Its-Kind Device Replaces Mitral Valve Without Open-Heart Surgery
- Innovation in Thermographic Neurosurgical Imaging Supports Informed Decision-Making
- Fluorescent Soft Robots Accurately Locate Early Gastric Cancer During Laparoscopic Surgery
Channels
Critical Care
view channel
Cuff-Free Blood Pressure Monitoring Device to Improve Early Detection and Management of Hypertension
Hypertension affects nearly half of all adults in the U.S. and remains the leading cause of cardiovascular disease. Regular and accurate blood pressure monitoring is essential for managing this condition,... Read more
New Understanding of Barrett’s Esophagus Formation to Enable Earlier Intervention and Diagnosis
Barrett’s esophagus is a condition in which the lining of the esophagus—normally composed of squamous epithelial cells—undergoes a transformation into cells resembling those found in the stomach or intestine.... Read morePatient Care
view channel
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more
VR Training Tool Combats Contamination of Portable Medical Equipment
Healthcare-associated infections (HAIs) impact one in every 31 patients, cause nearly 100,000 deaths each year, and cost USD 28.4 billion in direct medical expenses. Notably, up to 75% of these infections... Read more
Portable Biosensor Platform to Reduce Hospital-Acquired Infections
Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds
Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read moreHealth IT
view channel
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read more
Smartwatches Could Detect Congestive Heart Failure
Diagnosing congestive heart failure (CHF) typically requires expensive and time-consuming imaging techniques like echocardiography, also known as cardiac ultrasound. Previously, detecting CHF by analyzing... Read moreBusiness
view channel
Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies
A research collaboration will focus on the joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases. Bayer (Berlin, Germany) and... Read more